Clinical TrialsLilly’s EBGLYSS Reinforces Long-Term Disease Control in Atopic Dermatitis Lilly’s EBGLYSS Reinforces Long-Term Disease Control in Atopic Dermatitis Read Post »
Clinical TrialsSanofi Reports Phase 3 Success for Amlitelimab in Atopic Dermatitis Sanofi Reports Phase 3 Success for Amlitelimab in Atopic Dermatitis Read Post »
Clinical TrialsLenvima, Welireg Moves Closer to Approval with Japan Submission Lenvima, Welireg Moves Closer to Approval with Japan Submission Read Post »
Clinical TrialsAstraZeneca Reports Positive Phase III Data for Tozorakimab in COPD AstraZeneca Reports Positive Phase III Data for Tozorakimab in COPD Read Post »
Clinical TrialsWave’s RNA Therapy WVE-007 Shows Early Fat-Loss Signal in INLIGHT Trial Wave’s RNA Therapy WVE-007 Shows Early Fat-Loss Signal in INLIGHT Trial Read Post »
Clinical TrialsEncoded Aligns with FDA on Pivotal ENDEAVOR Trial Design for ETX101 in Drav... Encoded Aligns with FDA on Pivotal ENDEAVOR Trial Design for ETX101 in Drav... Read Post »
Clinical TrialsCompass Updates COMP360 Pipeline, Targets FDA Filing in TRD Compass Updates COMP360 Pipeline, Targets FDA Filing in TRD Read Post »
Clinical TrialsInnovent Reports Positive Phase 3 Data for IBI302 in Wet AMD Innovent Reports Positive Phase 3 Data for IBI302 in Wet AMD Read Post »
Clinical TrialsSarepta Advances siRNA Pipeline with Early FSHD and DM1 Trial Data Sarepta Advances siRNA Pipeline with Early FSHD and DM1 Trial Data Read Post »
Clinical TrialsNovo Nordisk, TUL Report Positive UBT251 Phase 2 Results Novo Nordisk, TUL Report Positive UBT251 Phase 2 Results Read Post »
Clinical TrialsOcugen’s OCU410 Demonstrates 31% Lesion Reduction in Phase 2 GA Trial Ocugen’s OCU410 Demonstrates 31% Lesion Reduction in Phase 2 GA Trial Read Post »
Clinical TrialsDizal Reports Positive Phase 3 Sunvozertinib Results in NSCLC Dizal Reports Positive Phase 3 Sunvozertinib Results in NSCLC Read Post »
Clinical TrialsApogee’s Zumilokibart Delivers 52-Week Control in Atopic Dermatitis Trial Apogee’s Zumilokibart Delivers 52-Week Control in Atopic Dermatitis Trial Read Post »
Clinical TrialsFDA Grants Priority Review to Ionis’ Zilganersen for Rare Alexander Disea... FDA Grants Priority Review to Ionis’ Zilganersen for Rare Alexander Disea... Read Post »
Clinical TrialsInsmed’s ARIKAYCE Hits Key Endpoints in Phase 3b ENCORE Trial Insmed’s ARIKAYCE Hits Key Endpoints in Phase 3b ENCORE Trial Read Post »
Clinical TrialsPfizer and Valneva Report >70% Efficacy for Lyme Vaccine Candidate in Phase... Pfizer and Valneva Report >70% Efficacy for Lyme Vaccine Candidate in Phase... Read Post »
Clinical TrialsRoche Stops Emugrobart in SMA and FSHD Trials After Weak Functional Outcome... Roche Stops Emugrobart in SMA and FSHD Trials After Weak Functional Outcome... Read Post »
Clinical TrialsBiohaven Completes Enrollment in Phase 2 Trial of Taldefgrobep for Obesity Biohaven Completes Enrollment in Phase 2 Trial of Taldefgrobep for Obesity Read Post »
Clinical TrialsBiogen-Eisai’s LEQEMBI Shows Strong Real-World Treatment Persistence ... Biogen-Eisai’s LEQEMBI Shows Strong Real-World Treatment Persistence ... Read Post »
Clinical TrialsSerum Institute Taps Eveliqure Platform for Anti-Diarrhoeal Vaccines in Chi... Serum Institute Taps Eveliqure Platform for Anti-Diarrhoeal Vaccines in Chi... Read Post »
Clinical TrialsChugai Files in Japan for Ocular Implant Component of Ranibizumab Port Deli... Chugai Files in Japan for Ocular Implant Component of Ranibizumab Port Deli... Read Post »
Clinical TrialsPfizer’s TALZENNA Combo Hits rPFS Goal in TALAPRO-3 Pfizer’s TALZENNA Combo Hits rPFS Goal in TALAPRO-3 Read Post »
Clinical TrialsSobi Explores Gamifant for Interferon-Gamma–Driven Sepsis in New Phase 2a... Sobi Explores Gamifant for Interferon-Gamma–Driven Sepsis in New Phase 2a... Read Post »
Clinical TrialsRhythm’s EMANATE Misses Endpoint, Highlights Subgroup Benefit Rhythm’s EMANATE Misses Endpoint, Highlights Subgroup Benefit Read Post »
Clinical TrialsPfizer’s Next-Gen CDK4 Inhibitor Shows Phase 2 Breast Cancer Benefit Pfizer’s Next-Gen CDK4 Inhibitor Shows Phase 2 Breast Cancer Benefit Read Post »
Clinical TrialsFDA Finds No Bioequivalence Deficiencies in NRx Preservative-Free Ketamine ... FDA Finds No Bioequivalence Deficiencies in NRx Preservative-Free Ketamine ... Read Post »
Clinical TrialsStructure Therapeutics’ Aleniglipron Demonstrates Strong Weight Loss Structure Therapeutics’ Aleniglipron Demonstrates Strong Weight Loss Read Post »
Clinical TrialsLilly Advances EBGLYSS Pediatric Indication After Positive ADorable-1 Trial... Lilly Advances EBGLYSS Pediatric Indication After Positive ADorable-1 Trial... Read Post »
Clinical TrialsCytomX Eyes Registrational Path for Varseta-M After Encouraging CRC Data CytomX Eyes Registrational Path for Varseta-M After Encouraging CRC Data Read Post »
Clinical TrialsBayer Reports Positive Phase III FIND-CKD Results for Finerenone Bayer Reports Positive Phase III FIND-CKD Results for Finerenone Read Post »
Clinical TrialsFDA Allows U.S. Enrollment in BioVersys Phase 3 Trial of BV100 for Drug-Res... FDA Allows U.S. Enrollment in BioVersys Phase 3 Trial of BV100 for Drug-Res... Read Post »
Clinical TrialsNRx Targets FDA Approval for NRX-100 in Severe Depression NRx Targets FDA Approval for NRX-100 in Severe Depression Read Post »
Clinical TrialsAbbott’s Libre CGM Improves HbA1c and Time-in-Range in FreeDM2 Trial Abbott’s Libre CGM Improves HbA1c and Time-in-Range in FreeDM2 Trial Read Post »
Clinical TrialsOtsuka’s Repinatrabit Cuts Blood Phe 67% in Adolescents with PKU Otsuka’s Repinatrabit Cuts Blood Phe 67% in Adolescents with PKU Read Post »
Clinical TrialsUnited’s Tyvaso Delivers Positive Phase 3 Results in IPF United’s Tyvaso Delivers Positive Phase 3 Results in IPF Read Post »
Clinical TrialsCapricor Reports New HOPE-3 Data Showing Deramiocel Improves Cardiac and Fu... Capricor Reports New HOPE-3 Data Showing Deramiocel Improves Cardiac and Fu... Read Post »
Clinical TrialsBridgeBio Unveils Strong Phase 3 Interim Data for BBP-418 in LGMD2I/R9 at M... BridgeBio Unveils Strong Phase 3 Interim Data for BBP-418 in LGMD2I/R9 at M... Read Post »
Clinical TrialsBioMarin Presents New VOXZOGO Data Supporting Early Treatment in Achondropl... BioMarin Presents New VOXZOGO Data Supporting Early Treatment in Achondropl... Read Post »
Clinical TrialsBiogen Initiates Phase 3 Program for Salanersen Following Promising Phase 1... Biogen Initiates Phase 3 Program for Salanersen Following Promising Phase 1... Read Post »
Clinical TrialsAscletis’ GLP-1 ASC30 Depot Injection Achieves Promising Phase 2 Results ... Ascletis’ GLP-1 ASC30 Depot Injection Achieves Promising Phase 2 Results ... Read Post »
Clinical TrialsTelix Reports Positive Safety Results from Phase 3 ProstACT Global Trial of... Telix Reports Positive Safety Results from Phase 3 ProstACT Global Trial of... Read Post »
Clinical TrialsVertex’s Povetacicept Cuts Proteinuria by 52% in Phase 3 RAINIER Interim ... Vertex’s Povetacicept Cuts Proteinuria by 52% in Phase 3 RAINIER Interim ... Read Post »
Clinical TrialsAbbVie Reports Up to 9.8% Weight Loss in Phase 1 MAD Trial of Long-Acting A... AbbVie Reports Up to 9.8% Weight Loss in Phase 1 MAD Trial of Long-Acting A... Read Post »
Clinical TrialsRegeneron, Hansoh Report 19.3% Weight Loss with Dual GLP-1/GIP Drug Olatore... Regeneron, Hansoh Report 19.3% Weight Loss with Dual GLP-1/GIP Drug Olatore... Read Post »
Clinical TrialsPfizer’s Trispecific Antibody Tilrekimig Shows Positive Phase 2 Results i... Pfizer’s Trispecific Antibody Tilrekimig Shows Positive Phase 2 Results i... Read Post »
Clinical TrialsRoche Reports Phase 3 persevERA Setback for Giredestrant in Breast Cancer Roche Reports Phase 3 persevERA Setback for Giredestrant in Breast Cancer Read Post »
Clinical TrialsImmunityBio Files Updated ANKTIVA sBLA with FDA for Papillary NMIBC ImmunityBio Files Updated ANKTIVA sBLA with FDA for Papillary NMIBC Read Post »
Clinical TrialsJOURNAVX Demonstrates High Opioid-Free Recovery Rate in Phase 4 Study JOURNAVX Demonstrates High Opioid-Free Recovery Rate in Phase 4 Study Read Post »
Clinical TrialsHelus Pharma Reports Positive Phase 2 Results for HLP004 in GAD Helus Pharma Reports Positive Phase 2 Results for HLP004 in GAD Read Post »
Clinical TrialsRoche’s Gazyva Shows Strong Phase III Success in Systemic Lupus: ALLEGORY... Roche’s Gazyva Shows Strong Phase III Success in Systemic Lupus: ALLEGORY... Read Post »
